Who are Tricortin 1000's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Purified Cortophin Gel, 40 U, Acthar low dose (40 U), Acthar high dose (80 U), H.P. Acthar Gel, Open label H.P. Acthar Gel, ACTHAR Gel (ACTH).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/tricortin-1000.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Tricortin 1000 — Competitive Intelligence Brief

Tricortin 1000 (Tricortin 1000) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: ACTH analog. Area: Endocrinology.

marketed ACTH analog Melanocortin-2 receptor (MC2R) Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

Tricortin 1000 (Tricortin 1000) — Fidia Farmaceutici s.p.a.. Tricortin 1000 is a corticotropin (ACTH) analog that stimulates the adrenal cortex to produce endogenous corticosteroids.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Tricortin 1000 TARGET	Tricortin 1000	Fidia Farmaceutici s.p.a.	marketed	ACTH analog	Melanocortin-2 receptor (MC2R)
Purified Cortophin Gel, 40 U	Purified Cortophin Gel, 40 U	Massachusetts General Hospital	marketed	ACTH analog / corticotropin	Melanocortin-2 receptor (MC2R)
Acthar low dose (40 U)	Acthar low dose (40 U)	NYU Langone Health	marketed	ACTH analog	Melanocortin-2 receptor (MC2R)
Acthar high dose (80 U)	Acthar high dose (80 U)	NYU Langone Health	marketed	ACTH analog	Melanocortin-2 receptor (MC2R)
H.P. Acthar Gel	H.P. Acthar Gel	Fiechtner, Justus J., M.D., P.C.	marketed	Corticotropin (ACTH analog)	Melanocortin-2 receptor (MC2R)
Open label H.P. Acthar Gel	Open label H.P. Acthar Gel	Fiechtner, Justus J., M.D., P.C.	marketed	Corticotropin (ACTH analog)	Melanocortin-2 receptor (MC2R)
ACTHAR Gel (ACTH)	ACTHAR Gel (ACTH)	University of Colorado, Denver	marketed	ACTH analog	Melanocortin-2 receptor (MC2R)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (ACTH analog class)

NYU Langone Health · 2 drugs in this class
Attune Health Research, Inc. · 1 drug in this class
Fidia Farmaceutici s.p.a. · 1 drug in this class
University of Colorado, Denver · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tricortin 1000 — Competitive Intelligence Brief. https://druglandscape.com/ci/tricortin-1000. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab